Aktie A14TKV ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Zhejiang Jiuzhou Pharmaceutical Co., Ltd

Aktien

A14TKV

CNE100001W36

603456

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 25.04.2024 		% 5 Tage % 1. Jan.
15,11 CNY +2,65 % Intraday Chart für Zhejiang Jiuzhou Pharmaceutical Co., Ltd -0,07 % -37,59 %
24.04. Zhejiang Jiuzhou Pharmaceutical Co., Ltd berichtet über die Ergebnisse für das erste Quartal bis zum 31. März 2024 CI
08.04. Zhejiang Jiuzhou Pharmaceutical Co., Ltd berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Jiuzhou Pharmaceutical Gets Nod to Market Sitagliptin Metformin Tablets; Shares Drop 4%
Ruibo Pharmaceutical Co., Ltd. announced that it expects to receive CNY 300 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Ruibo Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 15 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Tranche Update on Zhejiang Jiuzhou Pharmaceutical Co., Ltd's Equity Buyback Plan announced on January 5, 2024.
Jiuzhou Pharma to Build $42 Million CRO Platform in Japan
Zhejiang Jiuzhou Pharmaceutical Co., Ltd announces an Equity Buyback for CNY 100 million worth of its shares.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd authorizes a Buyback Plan.
Ruibo Pharmaceutical Technology Co., Ltd. announced that it has received CNY 50 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it has received CNY 100 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Ruibo Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 50 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Zhejiang Siwei Pharmaceutical Technology Co., Ltd announced that it expects to receive CNY 100 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Ruibo Pharmaceutical Technology Co., Ltd. announced that it has received CNY 20 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Ruibo Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 20 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Jiuzhou Pharmaceutical Logs Double-Digit Growth in H1 Earnings on Expanded CDMO Operations
Zhejiang Jiuzhou Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Jiuzhou Pharma to Set Up Singapore Subsidiary
Ruihua Pharmaceutical Co., Ltd. announced that it has received CNY 185 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A14TKV Aktie
  4. Nachrichten Zhejiang Jiuzhou Pharmaceutical Co., Ltd
  5. Andere Sprachen